BioPharma Dive - Latest News

3 ways to accelerate development and de-risk cell and gene therapy manufacturing

Development strategies designed to reduce the unknowns so that cell and gene therapy innovators can develop robust processes efficiently.

Mar 10, 2025 - 10:06
 0
3 ways to accelerate development and de-risk cell and gene therapy manufacturing

Development strategies designed to reduce the unknowns so that cell and gene therapy innovators can develop robust processes efficiently.

Read More

Tags:

Previous Article

75 years of the VW Bus – Volkswagen Commercial Vehicles is celebrating the birth...

Next Article

SynWeave™: Revolutionizing biopharma manufacturing by improving titer, timelines...

Related Posts

Tris to ask for approval of dual-acting pain drug

Tris to ask for approval of dual-acting pain drug

Mar 6, 2025  0

A brain biotech launches with Roche’s spare parts

A brain biotech launches with Roche’s spare parts

Feb 13, 2025  0

AstraZeneca’s next breast cancer drug; Madrigal’s accelerating MASH launch

AstraZeneca’s next breast cancer drug; Madrigal’s accel...

Feb 26, 2025  0